Compagnie Lombard Odier S Cm A Rubius Therapeutics, Inc. Transaction History

Compagnie Lombard Odier S Cm A

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 15, 2021	SELL	$22.26 - $28.43 $3.63 Million - $4.64 Million	-163,172 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$8.02 - $32.01 $1.31 Million - $5.22 Million	163,172 New	163,172 $4.39 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.